Arcus Biosciences President Sells Over $2 Million in Stock Under Trading Plan

Biotech company Arcus Biosciences, Inc. (NYSE: RCUS) announced that its president, Juan C. Jaen, sold approximately 96,859 shares of company stock in late October, at an average price of about $20.76 per share—bringing the total proceeds to just over $2 million under a previously established 10b5‑1 trading plan. The shares were sold across multiple transactions on October 28 and 29, 2025. The sales were carried out as scheduled under the trading plan adopted in August 2024. Following the transactions, Jaen still holds significant stock: 1,091,374 shares indirectly through a trust and 367,220 shares directly, according to the latest SEC filing. #ArcusBiosciences #InsiderTrading #BiotechStocks #10b51Plan #SlimScan #GrowthStocks #CANSLIM